Clinical Trial Update: FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients [NA]

View source ↗

Summary

Update on the FIM study evaluating the LAmbre II LAA occluder for non-valvular atrial fibrillation; the trial is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LAmbre II LAA Occluder

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Non-valvular Atrial Fibrillation (NVAF) | NA | Status: ACTIVE_NOT_RECRUITING